Pregnant or lactating females
Since the teratogenic potential of this combination is currently unknown, females who are pregnant or lactating are excluded. Males and females should perform abstinence or use barrier to prevent pregnancy.
Pregnant or lactating females
Pregnant or lactating females.
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females are excluded
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Lactating females and/or pregnant females
Pregnant or lactating females.
Pregnant females; (lactating females must agree not to breast feed while taking ibrutinib)
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Females who are pregnant or lactating
Pregnant or lactating females
Pregnant or lactating females
Females who are pregnant, lactating, or intend to become pregnant during their participation in the study
PART 1 EXCLUSION CRITERIA: Pregnant or lactating females
PART 2 GROUP 1 EXCLUSION CRITERIA: Pregnant or lactating females
PART 2 GROUP 2A EXCLUSION CRITERIA: Pregnant or lactating females
PART 2 GROUP 3 EXCLUSION CRITERIA: Pregnant or lactating females
Females who are pregnant, lactating, or intend to become pregnant during the participation of the study
Pregnant or lactating females
Females who are pregnant or lactating
Females who are pregnant or lactating
Pregnant or lactating females
Pregnant or lactating females
DONOR: Lactating females
Lactating females
DONOR: Females must not be pregnant or lactating
Pregnant or lactating female: all females of child-bearing potential must have a negative serum pregnancy test within 7 days of treatment; lactating females must discontinue breast feeding
Lactating females
Females who are pregnant or lactating
Lactating females
Lactating females
Pregnant or lactating females
No pregnant or lactating females
Patients must not be pregnant or lactating females.
Lactating females
Pregnant or lactating females
Pregnant or lactating females
Lactating females
Pregnant or lactating females
Lactating or pregnant females
Pregnant females; (lactating females must agree not to breast feed while taking the study medications)
Pregnant or lactating females
Women who are pregnant or lactating due to potential exposure of the fetus to RT and unknown effects of RT to lactating females
Pregnant and lactating females will be excluded
Pregnant or lactating females
Lactating females
Lactating females must agree to discontinue nursing
Females who are pregnant or lactating or plan to become pregnant during the course of this study.
Pregnant or lactating females
Lactating females.
Pregnant or lactating females
Lactating females
Pregnant or lactating females
Lactating females
Pregnant or lactating females
Lactating or pregnant females
Lactating females are not eligible
DONOR: Pregnant or lactating females
Pregnant or lactating females who chose to breast feed
Pregnant or lactating females
Lactating or pregnant females
Lactating females
Lactating or pregnant females
Pregnant or lactating females.
Females who are pregnant or lactating.
Unrelated Donor: Pregnant or lactating females
Pregnant or lactating (breastfeeding) females.
DONOR: Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females.
Lactating females
Pregnant or lactating females
Females who are pregnant or lactating
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant females (lactating females must agree not to breast feed while taking carfilzomib, lenalidomide or romidepsin)
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
No pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females.
Pregnant or lactating females
Pregnant or lactating females
Lactating females
Pregnant or lactating females
Lactating females
Pregnant or lactating females
Pregnant females; (lactating females must agree not to breastfeed while taking lenalidomide or romidepsin)
Pregnant or lactating females
Pregnant or lactating females
Females who are pregnant or lactating
DONOR: Pregnant or lactating females
Females who are pregnant or lactating
Pregnancy or lactating females
Pregnant or lactating females.
Females who are pregnant or lactating.
Pregnant or lactating females
Pregnant or lactating females.
Pregnant or lactating females.
Lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Male or non-pregnant, non-lactating, females
Pregnant or lactating females
Pregnant or lactating females
Suspected pregnancy, pregnant or lactating females
Females who are pregnant or lactating
Pregnant or lactating females
Pregnant, lactating or breastfeeding females
Lactating females or pregnant females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females.
Pregnant or lactating females.
Pregnant or lactating females
Females who are pregnant or lactating
Pregnant or lactating females are excluded from enrollment on this trial
Females who are pregnant or lactating
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating females
HEALTHY VOLUNTEER: Females who are pregnant or nursing or are actively lactating
Pregnant or lactating females
Females who are pregnant or lactating or who intend to become pregnant during participation in the study are not eligible to participate.
Females who are pregnant and/or lactating
Females who are lactating or pregnant.
Pregnant or lactating females